Aptevo Therapeutics Inc.

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Kevin C Tang. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Kevin C Tang telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:AUPH / Aurinia Pharmaceuticals Inc. Director 11,329,500
US:OMIC / Singular Genomics Systems, Inc. 10% Owner 0
US:TCRR / Tcr2 Therapeutics Inc 10% Owner 0
10% Owner 0
US:JNCE / Jounce Therapeutics Inc Director, 10% Owner 10,000
US:LJPC / La Jolla Pharmaceutical Co. Director, 10% Owner 0
US:APVO / Aptevo Therapeutics Inc. 0
US:ODT / Odonate Therapeutics Inc Chief Executive Officer, Director, 10% Owner 12,767,435
US:HRTX / Heron Therapeutics, Inc. 0
US:CYCC / Cyclacel Pharmaceuticals, Inc. 10% Owner 559,900
US:MRTX / Mirati Therapeutics, Inc. 10% Owner 1,238,543
US:RDEA / Ardea Biosciences, Inc. Director, 10% Owner 0
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Kevin C Tang. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam APVO / Aptevo Therapeutics Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di APVO / Aptevo Therapeutics Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2020-11-06 APVO TANG KEVIN C 34,044 20.6300 1,011 694.5433 702,328 5 48.3600 -653,435 -93.04
2020-11-06 APVO TANG KEVIN C 29,682 22.3300 882 751.7767 662,799
2020-11-06 APVO TANG KEVIN C 107,901 23.4800 3,205 790.4933 2,533,515
2020-11-06 APVO TANG KEVIN C 2,650 23.8700 79 803.6233 63,256
2020-11-05 APVO TANG KEVIN C 160,000 15.3100 4,752 515.4367 2,449,600
2020-11-05 APVO TANG KEVIN C 77,133 14.2200 2,291 478.7400 1,096,831
2020-11-05 APVO TANG KEVIN C 71,241 15.3200 2,116 515.7733 1,091,412
2020-11-05 APVO TANG KEVIN C 171,626 23.7900 5,098 800.9300 4,082,983
2020-11-05 APVO TANG KEVIN C 137,241 20.7800 4,076 699.5933 2,851,868
2020-11-05 APVO TANG KEVIN C 8,482 20.9400 252 704.9800 177,613
2020-11-04 APVO TANG KEVIN C 68,296 10.6300 2,029 357.8767 725,986
2020-11-04 APVO TANG KEVIN C 88,379 13.1100 2,625 441.3700 1,158,649
2020-11-04 APVO TANG KEVIN C 160,000 13.8300 4,752 465.6100 2,212,800
2020-11-04 APVO TANG KEVIN C 99,854 13.6500 2,966 459.5500 1,363,007
2020-11-04 APVO TANG KEVIN C 60,146 16.3300 1,787 549.7767 982,184
2020-11-04 APVO TANG KEVIN C 160,000 16.8400 4,752 566.9467 2,694,400

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

APVO / Aptevo Therapeutics Inc. Insider Trades
Penjualan Orang Dalam APVO / Aptevo Therapeutics Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di APVO / Aptevo Therapeutics Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2021-11-23 APVO TANG KEVIN C 161,336 13.5216 4,792 455.2272 2,181,521 331 2.67 -2,168,725 -99.41
2021-11-23 APVO TANG KEVIN C 124,509 12.4504 3,698 419.1635 1,550,187
2021-11-23 APVO TANG KEVIN C 75,491 11.7422 2,242 395.3207 886,430
2021-11-23 APVO TANG KEVIN C 149,111 11.1892 4,429 376.7031 1,668,433
2021-11-23 APVO TANG KEVIN C 50,889 10.4279 1,512 351.0726 530,665
2021-11-23 APVO TANG KEVIN C 200,000 10.0722 5,941 339.0974 2,014,440
2021-11-23 APVO TANG KEVIN C 160,000 9.6035 4,752 323.3178 1,536,560
2021-11-22 APVO TANG KEVIN C 16,667 7.3589 495 247.7496 122,651
2021-11-22 APVO TANG KEVIN C 196,281 7.1081 5,830 239.3060 1,395,185
2021-11-22 APVO TANG KEVIN C 3,719 6.6627 110 224.3109 24,779
2021-11-22 APVO TANG KEVIN C 38,664 6.5532 1,148 220.6244 253,373
2021-11-19 APVO TANG KEVIN C 30,467 8.0123 905 269.7474 244,111
2021-11-19 APVO TANG KEVIN C 183,333 7.5205 5,446 253.1902 1,378,756
2021-11-18 APVO TANG KEVIN C 43,213 9.3845 1,284 315.9448 405,532
2021-11-18 APVO TANG KEVIN C 152,764 8.3234 4,538 280.2211 1,271,516
2021-11-18 APVO TANG KEVIN C 4,023 8.0015 119 269.3838 32,190
2021-11-18 APVO TANG KEVIN C 169,533 8.0947 5,036 272.5216 1,372,319

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

APVO / Aptevo Therapeutics Inc. Insider Trades
Pembelian Orang Dalam AUPH / Aurinia Pharmaceuticals Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di APVO / Aptevo Therapeutics Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2025-08-05 AUPH TANG KEVIN C 200,000 11.6800 200,000 11.6800 2,336,000 30 12.5300 170,000 7.28
2025-08-04 AUPH TANG KEVIN C 100,000 11.3400 100,000 11.3400 1,134,000
2025-08-01 AUPH TANG KEVIN C 1,000,000 10.1200 1,000,000 10.1200 10,120,000
2025-03-04 AUPH TANG KEVIN C 148,038 8.0000 148,038 8.0000 1,184,304
2025-03-04 AUPH TANG KEVIN C 500,000 7.9200 500,000 7.9200 3,960,000
2025-03-04 AUPH TANG KEVIN C 100,000 8.0900 100,000 8.0900 809,000
2025-03-03 AUPH TANG KEVIN C 100,720 7.9700 100,720 7.9700 802,738
2025-03-03 AUPH TANG KEVIN C 351,962 8.0200 351,962 8.0200 2,822,735
2025-02-28 AUPH TANG KEVIN C 399,280 7.8500 399,280 7.8500 3,134,348
2024-12-09 AUPH TANG KEVIN C 500,000 9.0900 500,000 9.0900 4,545,000
2024-12-06 AUPH TANG KEVIN C 400,000 9.0100 400,000 9.0100 3,604,000
2024-12-05 AUPH TANG KEVIN C 300,000 8.9100 300,000 8.9100 2,673,000

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

AUPH / Aurinia Pharmaceuticals Inc. Insider Trades
Penjualan Orang Dalam AUPH / Aurinia Pharmaceuticals Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di APVO / Aptevo Therapeutics Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

AUPH / Aurinia Pharmaceuticals Inc. Insider Trades
Pembelian Orang Dalam CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di APVO / Aptevo Therapeutics Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2017-02-23 CYCC TANG KEVIN C 134,200 4.3374 8,133 71.5671 582,079 40 2451 19,351,904 3,324.62

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock - 6.0% Insider Trades
Penjualan Orang Dalam CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di APVO / Aptevo Therapeutics Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock - 6.0% Insider Trades
Pembelian Orang Dalam HRTX / Heron Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di APVO / Aptevo Therapeutics Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2019-10-04 HRTX TANG KEVIN C 285,714 17.5000 285,714 17.5000 4,999,995 60 26.6100 2,602,855 52.06
2018-03-29 HRTX TANG KEVIN C 192,308 26.0000 192,308 26.0000 5,000,008
2017-01-19 HRTX TANG KEVIN C 2,459,016 12.2000 2,459,016 12.2000 29,999,995
2015-06-10 HRTX TANG KEVIN C 121,212 24.7500 121,212 24.7500 2,999,997
2015-06-02 HRTX TANG KEVIN C 32,395 23.8399 32,395 23.8399 772,294
2015-06-01 HRTX TANG KEVIN C 2,380 19.3000 2,380 19.3000 45,934
2015-05-29 HRTX TANG KEVIN C 115,225 19.7358 115,225 19.7358 2,274,058
2014-06-25 HRTX TANG KEVIN C 510,638 11.7500 510,638 11.7500 5,999,996

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

HRTX / Heron Therapeutics, Inc. Insider Trades
Penjualan Orang Dalam HRTX / Heron Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di APVO / Aptevo Therapeutics Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2018-09-12 HRTX TANG KEVIN C 2,695,000 35.7500 2,695,000 35.7500 96,346,250 324 16.3600 -52,256,050 -54.24

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

HRTX / Heron Therapeutics, Inc. Insider Trades
Pembelian Orang Dalam ODTC / Odonate, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di APVO / Aptevo Therapeutics Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2020-12-23 ODT TANG KEVIN C 63,354 15.4282 63,354 15.4282 977,438 47 27.39 757,828 77.53
2020-12-23 ODT TANG KEVIN C 75,784 15.7080 75,784 15.7080 1,190,415
2020-12-22 ODT TANG KEVIN C 37,856 14.5754 37,856 14.5754 551,766
2020-12-22 ODT TANG KEVIN C 36,646 15.1673 36,646 15.1673 555,821
2020-12-21 ODT TANG KEVIN C 62,144 14.5753 62,144 14.5753 905,767
2020-09-29 ODT TANG KEVIN C 10,882 13.8484 10,882 13.8484 150,698
2020-09-28 ODT TANG KEVIN C 100,000 13.0571 100,000 13.0571 1,305,710
2020-08-28 ODT TANG KEVIN C 1,052,631 14.2500 1,052,631 14.2500 14,999,992
2019-06-26 ODT TANG KEVIN C 769,231 26.0000 769,231 26.0000 20,000,006
2019-06-18 ODT TANG KEVIN C 21,350 26.8862 21,350 26.8862 574,020
2019-06-17 ODT TANG KEVIN C 1,905 26.1999 1,905 26.1999 49,911
2019-06-17 ODT TANG KEVIN C 8,137 26.9535 8,137 26.9535 219,321
2019-06-14 ODT TANG KEVIN C 18,608 24.9513 18,608 24.9513 464,294
2019-06-07 ODT TANG KEVIN C 20,000 26.3110 20,000 26.3110 526,220
2019-06-06 ODT TANG KEVIN C 6,308 27.5579 6,308 27.5579 173,835
2019-06-06 ODT TANG KEVIN C 41,312 27.7052 41,312 27.7052 1,144,557
2019-06-06 ODT TANG KEVIN C 8,688 27.9517 8,688 27.9517 242,844
2019-06-05 ODT TANG KEVIN C 9,972 25.1382 9,972 25.1382 250,678
2019-06-05 ODT TANG KEVIN C 29,484 26.1112 29,484 26.1112 769,863
2019-06-04 ODT TANG KEVIN C 34,714 24.9156 34,714 24.9156 864,920
2019-06-04 ODT TANG KEVIN C 4,236 24.9886 4,236 24.9886 105,852
2019-06-03 ODT TANG KEVIN C 7,859 22.1605 7,859 22.1605 174,159
2019-06-03 ODT TANG KEVIN C 7,427 22.8551 7,427 22.8551 169,745
2019-03-08 ODT TANG KEVIN C 22,863 18.1039 22,863 18.1039 413,909
2019-03-08 ODT TANG KEVIN C 77,137 18.9361 77,137 18.9361 1,460,674
2019-03-07 ODT TANG KEVIN C 19,036 16.5627 19,036 16.5627 315,288
2019-03-07 ODT TANG KEVIN C 964 17.1526 964 17.1526 16,535
2019-03-07 ODT TANG KEVIN C 20,000 17.4955 20,000 17.4955 349,910
2018-12-31 ODT TANG KEVIN C 10,000 13.4201 10,000 13.4201 134,201
2018-12-31 ODT TANG KEVIN C 10,000 13.5070 10,000 13.5070 135,070
2018-12-31 ODT TANG KEVIN C 10,000 13.9866 10,000 13.9866 139,866
2018-12-31 ODT TANG KEVIN C 3,700 13.9978 3,700 13.9978 51,792
2018-12-28 ODT TANG KEVIN C 10,000 12.0394 10,000 12.0394 120,394
2018-12-28 ODT TANG KEVIN C 10,000 13.3469 10,000 13.3469 133,469
2018-12-27 ODT TANG KEVIN C 10,000 12.0315 10,000 12.0315 120,315
2018-12-26 ODT TANG KEVIN C 10,000 12.3966 10,000 12.3966 123,966
2018-12-26 ODT TANG KEVIN C 10,000 12.3384 10,000 12.3384 123,384
2018-12-26 ODT TANG KEVIN C 10,000 12.0937 10,000 12.0937 120,937
2018-12-21 ODT TANG KEVIN C 10,000 12.2731 10,000 12.2731 122,731
2018-12-21 ODT TANG KEVIN C 3,500 12.4364 3,500 12.4364 43,527
2018-12-21 ODT TANG KEVIN C 6,500 13.7799 6,500 13.7799 89,569
2018-12-20 ODT TANG KEVIN C 10,000 13.1742 10,000 13.1742 131,742
2018-12-18 ODT TANG KEVIN C 1,704 15.1770 1,704 15.1770 25,862
2018-12-18 ODT TANG KEVIN C 10,000 14.1327 10,000 14.1327 141,327
2018-12-17 ODT TANG KEVIN C 9,550 14.5070 9,550 14.5070 138,542
2018-12-17 ODT TANG KEVIN C 450 15.2000 450 15.2000 6,840
2018-12-17 ODT TANG KEVIN C 8,296 14.8542 8,296 14.8542 123,230
2018-12-14 ODT TANG KEVIN C 10,000 15.0838 10,000 15.0838 150,838
2018-12-12 ODT TANG KEVIN C 4,550 15.6522 4,550 15.6522 71,218
2018-12-12 ODT TANG KEVIN C 10,000 15.7728 10,000 15.7728 157,728
2018-12-11 ODT TANG KEVIN C 5,450 15.2528 5,450 15.2528 83,128
2018-12-07 ODT TANG KEVIN C 9,500 14.9780 9,500 14.9780 142,291
2018-12-06 ODT TANG KEVIN C 10,000 14.6243 10,000 14.6243 146,243
2018-12-06 ODT TANG KEVIN C 500 14.6598 500 14.6598 7,330
2018-11-27 ODT TANG KEVIN C 3,063 15.6423 3,063 15.6423 47,912
2018-11-26 ODT TANG KEVIN C 6,937 15.4312 6,937 15.4312 107,046
2018-11-23 ODT TANG KEVIN C 4,644 15.2520 4,644 15.2520 70,830
2018-11-21 ODT TANG KEVIN C 5,356 15.1495 5,356 15.1495 81,141
2018-11-01 ODT TANG KEVIN C 10,000 14.8727 10,000 14.8727 148,727
2018-10-29 ODT TANG KEVIN C 10,000 14.9642 10,000 14.9642 149,642
2018-10-26 ODT TANG KEVIN C 235 15.8500 235 15.8500 3,725
2018-10-25 ODT TANG KEVIN C 9,765 15.7767 9,765 15.7767 154,059
2018-10-24 ODT TANG KEVIN C 3,313 15.6136 3,313 15.6136 51,728
2018-10-24 ODT TANG KEVIN C 10,000 14.6904 10,000 14.6904 146,904
2018-10-23 ODT TANG KEVIN C 10,000 15.4479 10,000 15.4479 154,479
2018-10-23 ODT TANG KEVIN C 6,687 15.4225 6,687 15.4225 103,130
2018-09-28 ODT TANG KEVIN C 3,801 18.9456 3,801 18.9456 72,012
2018-09-28 ODT TANG KEVIN C 10,000 19.1722 10,000 19.1722 191,722
2018-09-28 ODT TANG KEVIN C 20,000 19.3322 20,000 19.3322 386,644
2018-09-27 ODT TANG KEVIN C 6,199 18.7013 6,199 18.7013 115,929
2018-09-26 ODT TANG KEVIN C 10,000 19.0664 10,000 19.0664 190,664
2018-09-25 ODT TANG KEVIN C 10,000 19.6477 10,000 19.6477 196,477
2018-09-24 ODT TANG KEVIN C 10,000 20.2993 10,000 20.2993 202,993
2018-09-24 ODT TANG KEVIN C 10,000 19.9839 10,000 19.9839 199,839
2018-09-20 ODT TANG KEVIN C 7,983 19.7521 7,983 19.7521 157,681
2018-09-20 ODT TANG KEVIN C 10,000 20.0788 10,000 20.0788 200,788
2018-09-20 ODT TANG KEVIN C 10,000 20.4267 10,000 20.4267 204,267
2018-09-19 ODT TANG KEVIN C 10,000 19.3086 10,000 19.3086 193,086
2018-09-19 ODT TANG KEVIN C 2,017 19.4783 2,017 19.4783 39,288
2018-09-18 ODT TANG KEVIN C 10,000 19.3387 10,000 19.3387 193,387
2018-09-18 ODT TANG KEVIN C 10,000 19.3366 10,000 19.3366 193,366
2018-09-18 ODT TANG KEVIN C 10,000 19.0290 10,000 19.0290 190,290
2018-09-18 ODT TANG KEVIN C 10,000 19.2982 10,000 19.2982 192,982
2018-09-18 ODT TANG KEVIN C 10,000 19.4161 10,000 19.4161 194,161
2018-08-21 ODT TANG KEVIN C 7,505 19.4738 7,505 19.4738 146,151
2018-08-20 ODT TANG KEVIN C 10,108 18.9566 10,108 18.9566 191,613
2018-08-17 ODT TANG KEVIN C 2,387 19.2625 2,387 19.2625 45,980
2018-08-16 ODT TANG KEVIN C 17,190 19.4638 17,190 19.4638 334,583
2018-08-16 ODT TANG KEVIN C 20,000 19.8049 20,000 19.8049 396,098
2018-08-15 ODT TANG KEVIN C 6,606 19.1115 6,606 19.1115 126,251
2018-08-15 ODT TANG KEVIN C 2,810 18.8582 2,810 18.8582 52,992
2018-08-14 ODT TANG KEVIN C 6,603 18.9841 6,603 18.9841 125,352
2018-08-13 ODT TANG KEVIN C 6,791 18.7175 6,791 18.7175 127,111
2018-03-01 ODT TANG KEVIN C 4,401 27.6071 4,401 27.6071 121,499
2018-02-28 ODT TANG KEVIN C 4,050 27.7302 4,050 27.7302 112,307
2018-02-28 ODT TANG KEVIN C 5,599 27.0362 5,599 27.0362 151,376
2018-02-27 ODT TANG KEVIN C 6,641 27.2615 6,641 27.2615 181,044
2018-02-27 ODT TANG KEVIN C 5,950 26.9313 5,950 26.9313 160,241
2018-02-26 ODT TANG KEVIN C 487 28.0000 487 28.0000 13,636
2018-02-26 ODT TANG KEVIN C 10,000 27.7048 10,000 27.7048 277,048
2018-02-26 ODT TANG KEVIN C 3,359 27.3244 3,359 27.3244 91,783
2018-02-23 ODT TANG KEVIN C 2,175 27.9938 2,175 27.9938 60,887
2018-02-22 ODT TANG KEVIN C 10,000 27.2883 10,000 27.2883 272,883
2018-02-22 ODT TANG KEVIN C 7,338 27.9616 7,338 27.9616 205,182
2018-02-21 ODT TANG KEVIN C 3,432 27.7170 3,432 27.7170 95,125
2018-02-21 ODT TANG KEVIN C 10,000 27.9535 10,000 27.9535 279,535
2018-02-20 ODT TANG KEVIN C 8,313 25.1517 8,313 25.1517 209,086
2018-02-16 ODT TANG KEVIN C 29,109 23.7203 29,109 23.7203 690,474
2018-02-16 ODT TANG KEVIN C 20,000 24.3710 20,000 24.3710 487,420
2018-02-16 ODT TANG KEVIN C 8,255 24.5370 8,255 24.5370 202,553
2018-02-15 ODT TANG KEVIN C 34,943 21.9808 34,943 21.9808 768,075
2018-02-14 ODT TANG KEVIN C 35,948 20.3856 35,948 20.3856 732,822
2017-12-07 ODT TANG KEVIN C 1,291,666 24.0000 1,291,666 24.0000 30,999,984

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

ODTC / Odonate, Inc. Insider Trades
Penjualan Orang Dalam ODTC / Odonate, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di APVO / Aptevo Therapeutics Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2021-11-19 ODT TANG KEVIN C 365,289 1.9161 365,289 1.9161 699,930 49 1.0900 -301,765 -43.11
2021-11-18 ODT TANG KEVIN C 212,423 1.9708 212,423 1.9708 418,643
2021-11-18 ODT TANG KEVIN C 500,000 1.8812 500,000 1.8812 940,600
2021-11-18 ODT TANG KEVIN C 381,842 1.8925 381,842 1.8925 722,636
2021-11-17 ODT TANG KEVIN C 468,849 2.6583 468,849 2.6583 1,246,341
2021-11-17 ODT TANG KEVIN C 31,151 1.9941 31,151 1.9941 62,118
2021-11-17 ODT TANG KEVIN C 500,000 2.0161 500,000 2.0161 1,008,050
2021-11-17 ODT TANG KEVIN C 287,577 2.1985 287,577 2.1985 632,238

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

ODTC / Odonate, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Kevin C Tang sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-08-05 2025-08-05 4 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
P - Purchase 200,000 11,329,500 1.80 11.68 2,336,000 132,328,560
2025-08-05 2025-08-04 4 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
P - Purchase 100,000 11,129,500 0.91 11.34 1,134,000 126,208,530
2025-08-05 2025-08-01 4 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
P - Purchase 1,000,000 11,029,500 9.97 10.12 10,120,000 111,618,540
2025-03-04 2025-03-04 4 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
P - Purchase 100,000 10,029,500 1.01 8.09 809,000 81,138,655
2025-03-04 2025-03-04 4 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
P - Purchase 500,000 9,929,500 5.30 7.92 3,960,000 78,641,640
2025-03-04 2025-03-04 4 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
P - Purchase 148,038 9,429,500 1.59 8.00 1,184,304 75,436,000
2025-03-04 2025-03-03 4 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
P - Purchase 351,962 9,281,462 3.94 8.02 2,822,735 74,437,325
2025-03-04 2025-03-03 4 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
P - Purchase 100,720 8,929,500 1.14 7.97 802,738 71,168,115
2025-03-04 2025-02-28 4 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
P - Purchase 399,280 8,828,780 4.74 7.85 3,134,348 69,305,923
2025-02-27 2025-02-21 4 OMIC Singular Genomics Systems, Inc.
Common Stock
D - Sale to Issuer -372,000 0 -100.00
2024-12-09 2024-12-09 4 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
P - Purchase 500,000 8,429,500 6.31 9.09 4,545,000 76,624,155
2024-12-09 2024-12-06 4 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
P - Purchase 400,000 7,929,500 5.31 9.01 3,604,000 71,444,795
2024-12-09 2024-12-05 4 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
P - Purchase 300,000 7,529,500 4.15 8.91 2,673,000 67,087,845
2024-09-23 3 AUPH Aurinia Pharmaceuticals Inc.
Common Shares
7,229,500
2024-09-18 3 OMIC Singular Genomics Systems, Inc.
Common Stock
249,584
2024-09-18 2024-09-18 4 OMIC Singular Genomics Systems, Inc.
Common Stock
P - Purchase 32,000 372,000 9.41 17.21 550,720 6,402,120
2024-09-18 2024-09-17 4 OMIC Singular Genomics Systems, Inc.
Common Stock
P - Purchase 40,000 340,000 13.33 15.33 613,200 5,212,200
2024-09-18 2024-09-16 4 OMIC Singular Genomics Systems, Inc.
Common Stock
P - Purchase 50,416 300,000 20.20 12.74 642,300 3,822,000
2024-02-14 2023-06-01 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
J - Other -4,394,800 0 -100.00
2024-02-02 2024-01-26 4 RAIN Rain Oncology Inc.
Common Stock
U - Other -3,850,513 0 -100.00
2023-12-18 2023-12-18 4 RAIN Rain Oncology Inc.
Common Stock
S - Sale -40,132 3,850,513 -1.03 1.21 -48,560 4,659,121
2023-12-18 2023-12-15 4 RAIN Rain Oncology Inc.
Common Stock
S - Sale -109,435 3,890,645 -2.74 1.20 -131,322 4,668,774
2023-12-18 2023-12-14 4 RAIN Rain Oncology Inc.
Common Stock
S - Sale -24,406 4,000,080 -0.61 1.21 -29,531 4,840,097
2023-10-13 2023-10-13 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 84,145 4,024,486 2.14 0.99 83,304 3,984,241
2023-10-13 2023-10-13 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 47,486 3,940,341 1.22 0.99 47,011 3,900,938
2023-10-13 2023-10-12 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 52,514 3,892,855 1.37 0.98 51,464 3,814,998
2023-10-13 2023-10-12 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 25,188 3,840,341 0.66 0.98 24,684 3,763,534
2023-10-13 2023-10-11 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 74,812 3,815,153 2.00 0.97 72,568 3,700,698
2023-06-01 3 RAIN Rain Oncology Inc.
Common Stock
2,652,068
2023-06-01 2023-06-01 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 240,341 3,740,341 6.87 1.12 269,182 4,189,182
2023-06-01 2023-06-01 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 92,984 3,500,000 2.73 1.09 101,353 3,815,000
2023-06-01 2023-05-31 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 5,000 3,407,016 0.15 1.10 5,500 3,747,718
2023-06-01 2023-05-31 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 161,180 3,402,016 4.97 1.08 174,074 3,674,177
2023-06-01 2023-05-30 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 5,930 3,240,836 0.18 1.06 6,286 3,435,286
2023-06-01 2023-05-30 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 2,016 3,234,906 0.06 1.08 2,177 3,493,698
2023-06-01 2023-05-30 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 32,890 3,232,890 1.03 1.06 34,863 3,426,863
2023-06-01 2023-05-30 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 200,000 3,200,000 6.67 1.00 200,000 3,200,000
2023-06-01 2023-05-30 4 RAIN Rain Oncology Inc.
Common Stock
P - Purchase 347,932 3,000,000 13.12 1.05 365,329 3,150,000
2023-05-30 2023-05-25 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
P - Purchase 50,000 4,394,800 1.15 1.72 86,000 7,559,056
2023-05-15 2023-05-12 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
P - Purchase 6,183 4,344,800 0.14 1.95 12,057 8,472,360
2023-05-15 2023-05-11 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
P - Purchase 38,765 4,338,617 0.90 1.95 75,592 8,460,303
2023-05-10 2023-05-10 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
P - Purchase 6,774 4,299,852 0.16 1.95 13,209 8,384,711
2023-05-10 2023-05-09 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
P - Purchase 20,141 4,293,078 0.47 1.95 39,275 8,371,502
2023-05-10 2023-05-08 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
P - Purchase 57,073 4,272,937 1.35 1.95 111,292 8,332,227
2023-05-05 2023-05-03 4 JNCE Jounce Therapeutics, Inc.
Common Stock
J - Other 10,000 10,000 9,737.70 97,377,000 97,377,000
2023-05-05 2023-05-03 4 JNCE Jounce Therapeutics, Inc.
Common Stock
U - Other -5,300,087 0 -100.00 1.85 -9,805,161
2023-05-05 3 TCRR TCR2 THERAPEUTICS INC.
Common Stock
3,926,287
2023-05-05 2023-05-05 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
P - Purchase 71,064 4,215,864 1.71 1.94 137,864 8,178,776
2023-05-05 2023-05-05 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
P - Purchase 95,759 4,144,800 2.36 1.90 181,942 7,875,120
2023-05-05 2023-05-04 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
P - Purchase 104,241 4,049,041 2.64 1.86 193,888 7,531,216
2023-05-05 2023-05-03 4 TCRR TCR2 THERAPEUTICS INC.
Common Stock
P - Purchase 18,513 3,944,800 0.47 1.85 34,249 7,297,880
2023-03-14 3 JNCE Jounce Therapeutics, Inc.
Common Stock
5,214,100
2023-03-14 2023-03-14 4 JNCE Jounce Therapeutics, Inc.
Common Stock
P - Purchase 20,286 5,300,087 0.38 1.02 20,651 5,395,489
2023-03-14 2023-03-13 4 JNCE Jounce Therapeutics, Inc.
Common Stock
P - Purchase 65,701 5,279,801 1.26 0.99 65,307 5,248,122
2022-08-24 2022-08-22 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
U - Other -9,607,934 0 -100.00 6.23 -59,857,429
2022-08-24 2022-08-22 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
U - Other -9,607,934 0 -100.00 6.23 -59,857,429
2022-01-14 2022-01-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 30,000 30,000
2021-12-01 2021-12-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -41,290 9,607,934 -0.43 3.66 -151,303 35,207,313
2021-12-01 2021-12-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -136,255 9,649,224 -1.39 3.76 -512,128 36,267,573
2021-12-01 2021-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -63,745 9,785,479 -0.65 3.95 -251,544 38,614,479
2021-12-01 2021-11-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -6,597 9,849,224 -0.07 3.95 -26,067 38,918,224
2021-12-01 2021-11-29 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
S - Sale -193,403 9,855,821 -1.92 4.10 -793,107 40,416,751
2021-11-26 2021-11-23 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -160,000 0 -100.00 9.60 -1,536,560
2021-11-26 2021-11-23 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -200,000 160,000 -55.56 10.07 -2,014,440 1,611,552
2021-11-26 2021-11-23 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -50,889 360,000 -12.39 10.43 -530,665 3,754,044
2021-11-26 2021-11-23 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -149,111 410,889 -26.63 11.19 -1,668,433 4,597,519
2021-11-26 2021-11-23 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -75,491 560,000 -11.88 11.74 -886,430 6,575,632
2021-11-26 2021-11-23 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -124,509 635,491 -16.38 12.45 -1,550,187 7,912,117
2021-11-26 2021-11-23 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -161,336 760,000 -17.51 13.52 -2,181,521 10,276,416
2021-11-22 2021-11-22 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -38,664 921,336 -4.03 6.55 -253,373 6,037,699
2021-11-22 2021-11-22 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -3,719 960,000 -0.39 6.66 -24,779 6,396,192
2021-11-22 2021-11-22 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -196,281 963,719 -16.92 7.11 -1,395,185 6,850,211
2021-11-22 2021-11-22 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -16,667 1,160,000 -1.42 7.36 -122,651 8,536,324
2021-11-22 2021-11-19 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -183,333 1,176,667 -13.48 7.52 -1,378,756 8,849,124
2021-11-22 2021-11-19 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -30,467 1,360,000 -2.19 8.01 -244,111 10,896,728
2021-11-22 2021-11-18 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -169,533 1,390,467 -10.87 8.09 -1,372,319 11,255,413
2021-11-22 2021-11-18 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -4,023 1,560,000 -0.26 8.00 -32,190 12,482,340
2021-11-22 2021-11-18 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -152,764 1,564,023 -8.90 8.32 -1,271,516 13,017,989
2021-11-22 2021-11-18 4 APVO Aptevo Therapeutics Inc.
Common Stock
S - Sale -43,213 1,716,787 -2.46 9.38 -405,532 16,111,188
2021-11-19 2021-11-19 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -365,289 12,767,435 -2.78 1.92 -699,930 24,463,682
2021-11-19 2021-11-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -381,842 13,132,724 -2.83 1.89 -722,636 24,853,680
2021-11-19 2021-11-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -500,000 13,514,566 -3.57 1.88 -940,600 25,423,602
2021-11-19 2021-11-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -212,423 14,014,566 -1.49 1.97 -418,643 27,619,907
2021-11-19 2021-11-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -287,577 14,226,989 -1.98 2.20 -632,238 31,278,035
2021-11-19 2021-11-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -500,000 14,514,566 -3.33 2.02 -1,008,050 29,262,817
2021-11-19 2021-11-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -31,151 15,014,566 -0.21 1.99 -62,118 29,940,546
2021-11-19 2021-11-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
S - Sale -468,849 15,045,717 -3.02 2.66 -1,246,341 39,996,030
2021-06-01 2021-06-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 43,734 10,049,224 0.44 4.53 198,014 45,499,872
2021-06-01 2021-06-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 15,358 10,005,490 0.15 4.29 65,917 42,943,563
2021-06-01 2021-05-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 184,642 9,990,132 1.88 4.47 825,978 44,689,856
2021-06-01 2021-05-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1,286 9,805,490 0.01 4.50 5,785 44,109,016
2021-05-26 2021-05-26 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 166,932 9,804,204 1.73 4.26 710,763 41,744,340
2021-05-26 2021-05-25 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 31,782 9,637,272 0.33 3.83 121,874 36,956,047
2021-05-26 2021-05-25 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 95,597 9,605,490 1.01 3.77 360,860 36,258,804
2021-05-26 2021-05-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 104,403 9,509,893 1.11 3.68 384,234 34,999,259
2021-05-04 2020-12-10 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 30,000 30,000
2021-02-16 2020-01-07 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -520,299 0 -100.00
2021-02-16 2020-01-06 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -1,600,000 0 -100.00
2020-12-23 2020-12-23 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 75,784 15,514,566 0.49 15.71 1,190,415 243,702,803
2020-12-23 2020-12-23 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 63,354 15,438,782 0.41 15.43 977,438 238,192,616
2020-12-23 2020-12-22 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 36,646 15,375,428 0.24 15.17 555,821 233,203,729
2020-12-23 2020-12-22 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 37,856 15,338,782 0.25 14.58 551,766 223,568,883
2020-12-23 2020-12-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 62,144 15,300,926 0.41 14.58 905,767 223,015,587
2020-11-06 2020-11-06 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 2,650 1,760,000 0.15 23.87 63,256 42,011,200
2020-11-06 2020-11-06 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 107,901 1,757,350 6.54 23.48 2,533,515 41,262,578
2020-11-06 2020-11-06 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 29,682 1,649,449 1.83 22.33 662,799 36,832,196
2020-11-06 2020-11-06 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 34,044 1,619,767 2.15 20.63 702,328 33,415,793
2020-11-06 2020-11-05 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 8,482 1,585,723 0.54 20.94 177,613 33,205,040
2020-11-06 2020-11-05 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 137,241 1,577,241 9.53 20.78 2,851,868 32,775,068
2020-11-06 2020-11-05 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 171,626 1,440,000 13.53 23.79 4,082,983 34,257,600
2020-11-06 2020-11-05 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 71,241 1,268,374 5.95 15.32 1,091,412 19,431,490
2020-11-06 2020-11-05 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 77,133 1,197,133 6.89 14.22 1,096,831 17,023,231
2020-11-06 2020-11-05 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 160,000 1,120,000 16.67 15.31 2,449,600 17,147,200
2020-11-06 2020-11-04 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 160,000 960,000 20.00 16.84 2,694,400 16,166,400
2020-11-06 2020-11-04 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 60,146 800,000 8.13 16.33 982,184 13,064,000
2020-11-06 2020-11-04 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 99,854 739,854 15.60 13.65 1,363,007 10,099,007
2020-11-06 2020-11-04 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 160,000 640,000 33.33 13.83 2,212,800 8,851,200
2020-11-06 2020-11-04 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 88,379 480,000 22.57 13.11 1,158,649 6,292,800
2020-11-06 2020-11-04 4 APVO Aptevo Therapeutics Inc.
Common Stock
P - Purchase 68,296 391,621 21.12 10.63 725,986 4,162,931
2020-11-06 3 APVO Aptevo Therapeutics Inc.
Common Stock
323,325
2020-09-30 2020-09-29 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,882 15,238,782 0.07 13.85 150,698 211,032,749
2020-09-30 2020-09-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 100,000 15,227,900 0.66 13.06 1,305,710 198,832,213
2020-09-09 2020-09-09 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 78,369 9,405,490 0.84 4.03 316,047 37,930,460
2020-09-09 2020-09-09 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 48,296 9,327,121 0.52 4.01 193,894 37,445,593
2020-09-09 2020-09-08 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 84,152 9,278,825 0.92 3.90 328,529 36,224,533
2020-09-09 2020-09-04 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 67,552 9,194,673 0.74 3.82 258,359 35,165,946
2020-09-01 2020-08-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 1,052,631 15,127,900 7.48 14.25 14,999,992 215,572,575
2020-08-14 2020-08-14 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 168,669 9,127,121 1.88 3.88 653,694 35,373,070
2020-08-14 2020-08-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 219,465 8,958,452 2.51 3.65 800,586 32,679,537
2020-08-14 2020-08-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 43,513 8,738,987 0.50 3.47 150,820 30,290,203
2020-06-04 2020-06-04 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 215,812 8,695,474 2.55 4.94 1,065,636 42,936,512
2020-06-04 2020-06-03 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 145,764 8,479,662 1.75 4.90 714,783 41,581,719
2020-06-04 2020-06-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 253,553 8,333,898 3.14 4.88 1,237,060 40,660,255
2020-02-14 2019-12-31 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -297,714 5,017,203 -5.60
2020-02-14 2019-12-31 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -121,500 5,017,203 -2.36
2020-02-14 2019-12-27 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -41,189 5,017,203 -0.81
2020-02-14 2019-12-23 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -201,000 5,017,203 -3.85
2020-02-14 2019-12-23 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -80,400 5,017,203 -1.58
2020-02-14 2019-12-19 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -20,402 5,017,203 -0.40
2020-02-14 2019-12-19 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -20,402 5,017,203 -0.40
2020-02-14 2019-08-13 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -230,000 5,017,203 -4.38
2020-02-14 2019-02-06 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -9,000 5,017,203 -0.18
2020-02-03 2020-02-03 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 75,003 8,080,345 0.94 6.80 509,833 54,926,145
2020-02-03 2020-01-31 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 13,292 8,005,342 0.17 6.75 89,705 54,026,452
2020-02-03 2020-01-30 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 81,475 7,992,050 1.03 6.72 547,431 53,698,584
2020-01-13 2020-01-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1,253,878 7,910,575 18.84 6.66 8,351,580 52,689,176
2020-01-13 2020-01-10 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 717,804 6,656,697 12.09 5.70 4,090,909 37,937,848
2020-01-13 2020-01-09 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 400,339 5,938,893 7.23 5.27 2,111,748 31,327,067
2020-01-13 2020-01-09 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 599,661 5,538,554 12.14 4.80 2,880,232 26,602,229
2019-12-23 2019-12-19 4 HRTX HERON THERAPEUTICS, INC. /DE/
Stock Option (right to buy)
A - Award 17,000 17,000
2019-12-23 2019-12-20 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 12,000 12,000
2019-10-07 2019-10-04 4 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
P - Purchase 285,714 5,799,810 5.18 17.50 4,999,995 101,496,675
2019-06-28 2019-06-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 769,231 14,075,269 5.78 26.00 20,000,006 365,956,994
2019-06-18 2019-06-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 21,350 13,306,038 0.16 26.89 574,020 357,748,799
2019-06-18 2019-06-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 8,137 13,284,688 0.06 26.95 219,321 358,068,838
2019-06-18 2019-06-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 1,905 13,276,551 0.01 26.20 49,911 347,844,309
2019-06-18 2019-06-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 18,608 13,274,646 0.14 24.95 464,294 331,219,675
2019-06-10 2019-06-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 20,000 13,256,038 0.15 26.31 526,220 348,779,616
2019-06-10 2019-06-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 8,688 13,236,038 0.07 27.95 242,844 369,969,763
2019-06-10 2019-06-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 41,312 13,227,350 0.31 27.71 1,144,557 366,466,377
2019-06-10 2019-06-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6,308 13,186,038 0.05 27.56 173,835 363,379,517
2019-06-05 2019-06-05 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 29,484 13,179,730 0.22 26.11 769,863 344,138,566
2019-06-05 2019-06-05 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 9,972 13,150,246 0.08 25.14 250,678 330,573,514
2019-06-05 2019-06-04 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 4,236 13,140,274 0.03 24.99 105,852 328,357,051
2019-06-05 2019-06-04 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 34,714 13,136,038 0.26 24.92 864,920 327,292,268
2019-06-05 2019-06-03 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 7,427 13,101,324 0.06 22.86 169,745 299,432,070
2019-06-05 2019-06-03 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 7,859 13,093,897 0.06 22.16 174,159 290,167,304
2019-03-11 2019-03-08 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 77,137 13,086,038 0.59 18.94 1,460,674 247,798,524
2019-03-11 2019-03-08 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 22,863 13,008,901 0.18 18.10 413,909 235,511,843
2019-03-11 2019-03-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 20,000 12,986,038 0.15 17.50 349,910 227,197,228
2019-03-11 2019-03-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 964 12,966,038 0.01 17.15 16,535 222,401,263
2019-03-11 2019-03-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 19,036 12,965,074 0.15 16.56 315,288 214,736,631
2019-02-14 2018-12-10 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -3,955 5,753,096 -0.07
2019-02-14 2018-12-10 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -2,025 5,757,051 -0.04
2019-02-14 2018-12-10 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -3,955 5,759,076 -0.07
2019-02-14 2018-12-10 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -3,955 5,763,031 -0.07
2019-02-14 2018-12-10 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -3,955 5,766,986 -0.07
2019-02-14 2018-12-10 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -19,304 5,770,941 -0.33
2019-02-14 2018-12-07 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -1,992 5,790,245 -0.03
2019-02-14 2018-12-07 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -18,989 5,792,237 -0.33
2019-02-14 2018-12-07 5 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
G - Gift -18,989 5,811,226 -0.33
2019-02-14 2018-09-11 5 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
G - Gift -500,000 3,638,893 -12.08
2019-01-25 2019-01-23 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 12,000 12,000
2019-01-09 2019-01-09 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 79,214 4,938,893 1.63 5.54 438,806 27,358,998
2019-01-09 2019-01-08 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 120,786 4,859,679 2.55 5.43 655,699 26,381,253
2019-01-09 2019-01-08 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 200,000 4,738,893 4.41 5.38 1,075,700 25,488,136
2019-01-09 2019-01-08 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 200,000 4,538,893 4.61 5.34 1,067,920 24,235,873
2019-01-09 2019-01-08 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 200,000 4,338,893 4.83 5.24 1,047,940 22,734,498
2019-01-09 2019-01-08 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 200,000 4,138,893 5.08 5.24 1,048,980 21,708,080
2019-01-09 2019-01-08 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 200,000 3,938,893 5.35 5.33 1,066,400 21,002,177
2019-01-09 2019-01-07 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 100,000 3,738,893 2.75 5.84 583,840 21,829,153
2018-12-31 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 3,700 12,946,038 0.03 14.00 51,792 181,216,051
2018-12-31 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,942,338 0.08 13.99 139,866 181,019,305
2018-12-31 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,932,338 0.08 13.51 135,070 174,677,089
2018-12-31 2018-12-31 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,922,338 0.08 13.42 134,201 173,419,068
2018-12-31 2018-12-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,912,338 0.08 13.35 133,469 172,339,684
2018-12-31 2018-12-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,902,338 0.08 12.04 120,394 155,336,408
2018-12-31 2018-12-27 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,892,338 0.08 12.03 120,315 155,114,165
2018-12-26 2018-12-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,882,338 0.08 12.09 120,937 155,795,131
2018-12-26 2018-12-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,872,338 0.08 12.34 123,384 158,824,055
2018-12-26 2018-12-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,862,338 0.08 12.40 123,966 159,449,259
2018-12-26 2018-12-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6,500 12,852,338 0.05 13.78 89,569 177,103,932
2018-12-26 2018-12-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 3,500 12,845,838 0.03 12.44 43,527 159,755,980
2018-12-26 2018-12-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,842,338 0.08 12.27 122,731 157,615,299
2018-12-26 2018-12-20 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,832,338 0.08 13.17 131,742 169,055,787
2018-12-18 2018-12-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,822,338 0.08 14.13 141,327 181,214,256
2018-12-18 2018-12-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 1,704 12,812,338 0.01 15.18 25,862 194,452,854
2018-12-18 2018-12-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 8,296 12,810,634 0.06 14.85 123,230 190,291,720
2018-12-18 2018-12-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 450 12,802,338 0.00 15.20 6,840 194,595,538
2018-12-18 2018-12-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 9,550 12,801,888 0.07 14.51 138,542 185,716,989
2018-12-18 2018-12-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,792,338 0.08 15.08 150,838 192,957,068
2018-12-18 2018-12-15 4 HRTX HERON THERAPEUTICS, INC. /DE/
Stock Option (right to buy)
A - Award 17,000 17,000
2018-12-13 2018-12-12 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,782,338 0.08 15.77 157,728 201,613,261
2018-12-13 2018-12-12 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 4,550 12,772,338 0.04 15.65 71,218 199,915,189
2018-12-13 2018-12-11 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 5,450 12,767,788 0.04 15.25 83,128 194,744,517
2018-12-10 2018-12-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 9,500 12,762,338 0.07 14.98 142,291 191,154,299
2018-12-10 2018-12-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 500 12,752,838 0.00 14.66 7,330 186,954,055
2018-12-10 2018-12-06 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,752,338 0.08 14.62 146,243 186,494,017
2018-11-29 2018-11-27 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 3,063 12,742,338 0.02 15.64 47,912 199,319,474
2018-11-26 2018-11-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6,937 12,739,275 0.05 15.43 107,046 196,582,300
2018-11-26 2018-11-23 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 4,644 12,732,338 0.04 15.25 70,830 194,193,619
2018-11-26 2018-11-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 5,356 12,727,694 0.04 15.15 81,141 192,818,200
2018-11-05 2018-11-01 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,722,338 0.08 14.87 148,727 189,215,516
2018-10-30 2018-10-29 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,712,338 0.08 14.96 149,642 190,229,968
2018-10-30 2018-10-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 235 12,702,338 0.00 15.85 3,725 201,332,057
2018-10-25 2018-10-25 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 9,765 12,702,103 0.08 15.78 154,059 200,397,268
2018-10-25 2018-10-24 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,692,338 0.08 14.69 146,904 186,455,522
2018-10-25 2018-10-24 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 3,313 12,682,338 0.03 15.61 51,728 198,016,953
2018-10-25 2018-10-23 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6,687 12,679,025 0.05 15.42 103,130 195,542,263
2018-10-25 2018-10-23 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,672,338 0.08 15.45 154,479 195,761,010
2018-10-01 2018-09-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 20,000 12,662,338 0.16 19.33 386,644 244,790,851
2018-10-01 2018-09-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,642,338 0.08 19.17 191,722 242,381,433
2018-10-01 2018-09-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 3,801 12,632,338 0.03 18.95 72,012 239,327,223
2018-10-01 2018-09-27 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6,199 12,628,537 0.05 18.70 115,929 236,170,059
2018-09-26 2018-09-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,622,338 0.08 19.07 190,664 240,662,545
2018-09-26 2018-09-25 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,612,338 0.08 19.65 196,477 247,803,433
2018-09-26 2018-09-24 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,602,338 0.08 19.98 199,839 251,843,862
2018-09-26 2018-09-24 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,592,338 0.08 20.30 202,993 255,615,647
2018-09-20 2018-09-20 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,582,338 0.08 20.43 204,267 257,015,644
2018-09-20 2018-09-20 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,572,338 0.08 20.08 200,788 252,437,460
2018-09-20 2018-09-20 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 7,983 12,562,338 0.06 19.75 157,681 248,132,556
2018-09-20 2018-09-19 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 2,017 12,554,355 0.02 19.48 39,288 244,537,493
2018-09-20 2018-09-19 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,552,338 0.08 19.31 193,086 242,368,074
2018-09-20 2018-09-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,542,338 0.08 19.42 194,161 243,523,289
2018-09-20 2018-09-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,532,338 0.08 19.30 192,982 241,851,565
2018-09-20 2018-09-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,522,338 0.08 19.03 190,290 238,287,570
2018-09-20 2018-09-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,512,338 0.08 19.34 193,366 241,946,075
2018-09-20 2018-09-18 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,502,338 0.08 19.34 193,387 241,778,964
2018-09-12 2018-09-12 4 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
S - Sale -2,695,000 5,830,215 -31.61 35.75 -96,346,250 208,430,186
2018-08-23 2018-08-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 7,505 12,492,338 0.06 19.47 146,151 243,273,292
2018-08-20 2018-08-20 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,108 12,484,833 0.08 18.96 191,613 236,669,985
2018-08-20 2018-08-17 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 2,387 12,474,725 0.02 19.26 45,980 240,294,390
2018-08-20 2018-08-16 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 20,000 12,472,338 0.16 19.80 396,098 247,013,407
2018-08-20 2018-08-16 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 17,190 12,452,338 0.14 19.46 334,583 242,369,816
2018-08-15 2018-08-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 2,810 12,435,148 0.02 18.86 52,992 234,504,508
2018-08-15 2018-08-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6,606 12,432,338 0.05 19.11 126,251 237,600,628
2018-08-15 2018-08-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6,603 12,425,732 0.05 18.98 125,352 235,891,339
2018-08-15 2018-08-13 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6,791 12,419,129 0.05 18.72 127,111 232,455,047
2018-04-02 2018-03-29 4 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
P - Purchase 192,308 8,525,215 2.31 26.00 5,000,008 221,655,590
2018-03-19 2018-03-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 508,474 4,138,893 14.01 29.50 14,999,983 122,097,344
2018-03-02 2018-03-01 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 4,401 12,412,338 0.04 27.61 121,499 342,668,656
2018-03-02 2018-02-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 5,599 12,407,937 0.05 27.04 151,376 335,463,466
2018-03-02 2018-02-28 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 4,050 12,402,338 0.03 27.73 112,307 343,919,313
2018-03-02 2018-03-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,630,419 0.28 30.44 304,435 110,522,661
2018-03-02 2018-02-28 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,620,419 0.28 30.15 301,540 109,170,115
2018-03-02 2018-02-28 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,610,419 0.28 30.12 301,171 108,735,350
2018-03-02 2018-02-28 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,600,419 0.28 29.54 295,381 106,349,536
2018-02-27 2018-02-27 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 5,950 12,398,288 0.05 26.93 160,241 333,902,014
2018-02-27 2018-02-27 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 6,641 12,392,338 0.05 27.26 181,044 337,833,722
2018-02-27 2018-02-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 3,359 12,385,697 0.03 27.32 91,783 338,431,739
2018-02-27 2018-02-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,382,338 0.08 27.70 277,048 343,050,198
2018-02-27 2018-02-26 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 487 12,372,338 0.00 28.00 13,636 346,425,464
2018-02-27 2018-02-23 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 2,175 12,371,851 0.02 27.99 60,887 346,335,123
2018-02-27 2018-02-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,590,419 0.28 30.60 306,037 109,880,106
2018-02-27 2018-02-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,580,419 0.28 30.69 306,880 109,875,898
2018-02-27 2018-02-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,570,419 0.28 30.87 308,725 110,227,761
2018-02-27 2018-02-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,560,419 0.28 30.88 308,796 109,944,315
2018-02-27 2018-02-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,550,419 0.28 30.57 305,714 108,541,279
2018-02-27 2018-02-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,540,419 0.28 32.17 321,728 113,905,192
2018-02-27 2018-02-27 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 9,000 3,530,419 0.26 32.70 294,284 115,438,347
2018-02-27 2018-02-26 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 1,000 3,521,419 0.03 32.50 32,502 114,453,160
2018-02-27 2018-02-26 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,520,419 0.28 32.48 324,821 114,350,602
2018-02-27 2018-02-26 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,510,419 0.29 32.92 329,160 115,548,952
2018-02-27 2018-02-23 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,500,419 0.29 32.30 323,046 113,079,636
2018-02-27 2018-02-23 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 20,000 3,490,419 0.58 32.58 651,600 113,717,851
2018-02-27 2018-02-23 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,470,419 0.29 32.42 324,186 112,506,125
2018-02-27 2018-02-23 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,460,419 0.29 31.94 319,442 110,540,317
2018-02-27 2018-02-23 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 3,450,419 0.29 31.54 315,413 108,830,701
2018-02-22 2018-02-22 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 7,338 12,369,676 0.06 27.96 205,182 345,875,932
2018-02-22 2018-02-22 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,362,338 0.08 27.29 272,883 337,347,188
2018-02-22 2018-02-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 10,000 12,352,338 0.08 27.95 279,535 345,291,080
2018-02-22 2018-02-21 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 3,432 12,342,338 0.03 27.72 95,125 342,092,582
2018-02-22 2018-02-20 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 8,313 12,338,906 0.07 25.15 209,086 310,344,462
2018-02-16 2018-02-16 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 8,255 12,330,593 0.07 24.54 202,553 302,555,760
2018-02-16 2018-02-16 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 20,000 12,322,338 0.16 24.37 487,420 300,307,699
2018-02-16 2018-02-16 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 29,109 12,302,338 0.24 23.72 690,474 291,815,148
2018-02-16 2018-02-15 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 34,943 12,273,229 0.29 21.98 768,075 269,775,392
2018-02-16 2018-02-14 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 35,948 12,238,286 0.29 20.39 732,822 249,484,803
2017-12-20 2017-12-18 4 HRTX HERON THERAPEUTICS, INC. /DE/
Stock Option (right to buy)
A - Award 17,000 17,000
2017-12-13 2017-12-11 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 10,000 10,000
2017-12-08 2017-12-07 4 ODT Odonate Therapeutics, Inc.
Common Stock
P - Purchase 1,291,666 12,202,338 11.84 24.00 30,999,984 292,856,112
2017-12-06 3 ODT Odonate Therapeutics, LLC
Common Stock
21,821,344
2017-12-06 3 ODT Odonate Therapeutics, LLC
Common Stock
21,821,344
2017-12-06 3 ODT Odonate Therapeutics, LLC
Common Stock
21,821,344
2017-12-06 3 ODT Odonate Therapeutics, LLC
Common Stock
21,821,344
2017-12-06 3 ODT Odonate Therapeutics, LLC
Common Stock
21,821,344
2017-03-27 2017-03-23 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 149,254 3,440,419 4.53 33.50 5,000,009 115,254,036
2017-03-06 2017-03-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 100,000 3,291,165 3.13 34.64 3,463,840 114,000,690
2017-02-27 2017-02-23 4 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
P - Purchase 134,200 559,900 31.52 4.34 582,079 2,428,510
2017-02-27 3 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
851,400
2017-02-27 3 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
851,400
2017-02-27 3 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
851,400
2017-02-27 3 CYCC Cyclacel Pharmaceuticals, Inc.
Common Stock
851,400
2017-01-23 2017-01-19 4 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
P - Purchase 2,459,016 8,332,907 41.86 12.20 29,999,995 101,661,465
2017-01-06 2017-01-04 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 10,000 10,000
2016-12-23 2016-12-21 4 HRTX HERON THERAPEUTICS, INC. /DE/
Stock Option (right to buy)
A - Award 17,000 17,000
2016-09-13 2016-09-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 16,448 3,191,165 0.52 20.28 333,514 64,706,934
2016-09-13 2016-09-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 22,587 3,174,717 0.72 19.92 449,886 63,233,696
2016-09-13 2016-09-09 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 100,000 3,152,130 3.28 19.72 1,971,970 62,159,058
2016-06-20 2016-06-16 4 HRTX HERON THERAPEUTICS, INC. /DE/
Warrant (Right to Buy)
M - Exercise -1,250,000 0 -100.00
2016-06-20 2016-06-16 4 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
F - Taxes -243,639 5,873,891 -3.98 18.47 -4,500,012 108,490,767
2016-06-20 2016-06-16 4 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
M - Exercise 1,250,000 6,117,530 25.68 3.60 4,500,000 22,023,108
2016-03-08 2016-03-04 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 20,000 3,052,130 0.66 19.85 396,928 60,573,793
2016-03-03 2016-03-03 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 20,000 3,032,130 0.66 18.93 378,560 57,392,157
2016-03-03 2016-03-03 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 20,000 3,012,130 0.67 18.55 370,906 55,860,854
2016-03-03 2016-03-03 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 20,000 2,992,130 0.67 18.72 374,488 56,025,839
2016-03-03 2016-03-03 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 13,500 2,972,130 0.46 18.91 255,280 56,201,789
2016-03-03 2016-03-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 6,500 2,958,630 0.22 18.77 121,985 55,524,313
2016-03-03 2016-03-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 20,000 2,952,130 0.68 18.08 361,528 53,363,883
2016-03-03 2016-03-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 4,028 2,932,130 0.14 17.86 71,926 52,357,579
2016-03-03 2016-03-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 15,972 2,928,102 0.55 16.94 270,598 49,607,904
2016-03-03 2016-03-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 20,000 2,912,130 0.69 16.13 322,502 46,958,387
2016-03-03 2016-03-01 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 20,000 2,892,130 0.70 16.19 323,714 46,811,149
2015-12-24 2015-12-22 4 HRTX HERON THERAPEUTICS, INC. /DE/
Stock Option (right to buy)
A - Award 17,000 17,000
2015-12-23 2015-12-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 10,000 10,000
2015-09-14 2015-09-10 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 80,000 2,872,130 2.87 38.00 3,040,000 109,140,940
2015-08-21 2015-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 2,792,130 0.36 29.94 299,413 83,600,002
2015-08-21 2015-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 2,782,130 0.36 28.25 282,505 78,596,564
2015-08-21 2015-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 2,772,130 0.36 27.82 278,150 77,106,796
2015-08-21 2015-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 2,762,130 0.36 26.73 267,280 73,826,211
2015-08-21 2015-08-21 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 2,752,130 0.36 25.72 257,167 70,775,702
2015-08-21 2015-08-20 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 2,742,130 0.37 26.54 265,448 72,789,292
2015-08-21 2015-08-20 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 2,732,130 0.37 26.85 268,549 73,371,078
2015-08-21 2015-08-20 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 2,722,130 0.37 26.97 269,710 73,418,568
2015-08-21 2015-08-20 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 2,712,130 0.37 26.66 266,583 72,300,775
2015-08-21 2015-08-20 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 2,702,130 0.37 27.17 271,685 73,412,819
2015-08-21 2015-08-19 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 30,000 2,692,130 1.13 27.59 827,697 74,275,597
2015-08-21 2015-08-19 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 2,662,130 0.38 26.98 269,782 71,819,476
2015-08-21 2015-08-19 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 10,000 2,652,130 0.38 26.26 262,585 69,640,956
2015-08-21 2015-08-19 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 20,000 2,642,130 0.76 26.13 522,676 69,048,897
2015-06-30 2015-06-26 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 110,000 2,622,130 4.38 23.58 2,593,470 61,821,959
2015-06-24 2015-06-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 88,314 2,512,130 3.64 22.94 2,026,188 57,635,799
2015-06-24 2015-06-23 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 53,836 2,423,816 2.27 22.27 1,198,739 53,969,899
2015-06-24 2015-06-22 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 77,850 2,369,980 3.40 21.41 1,666,597 50,736,058
2015-06-12 2015-06-10 4 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
P - Purchase 121,212 4,867,530 2.55 24.75 2,999,997 120,471,368
2015-06-02 2015-06-02 4 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
P - Purchase 32,395 4,746,318 0.69 23.84 772,294 113,151,746
2015-06-02 2015-06-01 4 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
P - Purchase 2,380 4,713,923 0.05 19.30 45,934 90,978,714
2015-06-02 2015-05-29 4 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
P - Purchase 115,225 4,711,543 2.51 19.74 2,274,058 92,986,070
2015-05-13 2015-05-13 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 47,483 2,292,130 2.12 18.63 884,532 42,698,714
2015-05-13 2015-05-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 44,400 2,244,647 2.02 18.25 810,362 40,967,950
2015-05-13 2015-05-11 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 98,700 2,200,247 4.70 18.04 1,780,548 39,692,456
2015-02-25 2015-02-23 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 10,000 10,000
2014-12-18 2014-12-16 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 582 2,101,547 0.03 13.95 8,117 29,308,805
2014-12-16 2014-12-12 4 HRTX HERON THERAPEUTICS, INC. /DE/
Stock Option (right to buy)
A - Award 17,000 17,000
2014-12-15 2014-12-15 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 32,343 2,100,965 1.56 13.93 450,574 29,268,754
2014-12-15 2014-12-12 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 77,304 2,068,622 3.88 13.71 1,059,846 28,361,014
2014-12-15 2014-12-11 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 122,696 1,991,318 6.57 12.01 1,473,910 23,921,106
2014-10-06 2014-10-02 4 LJPC LA JOLLA PHARMACEUTICAL CO
Stock Option (Right to Buy)
A - Award 18,000 18,000
2014-09-26 2014-09-26 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 44,055 1,868,622 2.41 9.21 405,861 17,214,867
2014-09-26 2014-09-25 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 30,500 1,824,567 1.70 9.17 279,688 16,731,462
2014-09-26 2014-09-24 4 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
P - Purchase 95,000 1,794,067 5.59 9.10 864,443 16,324,933
2014-08-04 3 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
3,398,134
2014-08-04 3 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
3,398,134
2014-08-04 3 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
3,398,134
2014-08-04 3 LJPC LA JOLLA PHARMACEUTICAL CO
Common Stock
3,398,134
2014-06-27 2014-06-25 4 HRTX HERON THERAPEUTICS, INC. /DE/
Common Stock
P - Purchase 510,638 4,596,318 12.50 11.75 5,999,996 54,006,736
2014-01-22 2014-01-10 4/A APPA HERON THERAPEUTICS, INC. /DE/
Stock Option (right to buy)
A - Award 29,500 29,500
2014-01-14 2014-01-10 4 APPA HERON THERAPEUTICS, INC. /DE/
Stock Option (right to buy)
A - Award 27,750 27,750
2013-11-22 2013-11-20 4 APPA AP PHARMA INC /DE/
Common Stock
A - Award 17,500,000 81,713,600 27.25 0.40 7,000,000 32,685,440
2013-10-28 2013-10-24 4 MRTX Mirati Therapeutics, Inc.
Common Stock
P - Purchase 57,143 1,238,543 4.84 17.50 1,000,002 21,674,502
2013-09-23 2013-09-20 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale -4,316 1,181,400 -0.36 16.25 -70,135 19,197,750
2013-09-23 2013-09-19 4 MRTX Mirati Therapeutics, Inc.
Common Stock
S - Sale -32,582 1,185,716 -2.67 16.35 -532,712 19,386,338
2013-07-15 3 MRTX Mirati Therapeutics, Inc.
Common Stock
1,218,298
2013-02-14 2012-12-19 5 APPA AP PHARMA INC /DE/
Common Stock
G - Gift -5,746,716 64,213,600 -8.21
2012-07-27 2012-07-25 4 APPA AP PHARMA INC /DE/
Common Stock
A - Award 9,523,810 69,960,316 15.76 0.52 5,000,000 36,729,166
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Common Stock Warrant (right to buy)
D - Sale to Issuer -39,163 0 -100.00 20.86 -816,940
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -12,500 0 -100.00 15.53 -194,125
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -12,500 0 -100.00 6.03 -75,375
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -12,500 0 -100.00 17.71 -221,375
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -2,500 0 -100.00 19.84 -49,600
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -5,000 0 -100.00 19.84 -99,200
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -12,500 0 -100.00 19.84 -248,000
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -7,500 0 -100.00 16.31 -122,325
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -12,500 0 -100.00 16.31 -203,875
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -2,500 0 -100.00 26.15 -65,375
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -1,250 0 -100.00 26.15 -32,688
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -12,500 0 -100.00 27.76 -347,000
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -12,500 0 -100.00 28.50 -356,250
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -10,000 0 -100.00 27.92 -279,200
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -25,000 0 -100.00 18.07 -451,750
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Non-Qualified Stock Option (right to buy)
D - Sale to Issuer -5,000 0 -100.00 15.51 -77,550
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Common Stock
D - Sale to Issuer -3,733,582 0 -100.00 32.00 -119,474,624
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Common Stock
D - Sale to Issuer -67,052 0 -100.00 32.00 -2,145,664
2012-06-20 2012-06-19 4 RDEA Ardea Biosciences, Inc./DE
Common Stock
D - Sale to Issuer -15,089 0 -100.00 32.00 -482,848
2012-05-31 2012-05-29 4 APPA AP PHARMA INC /DE/
Non-Qualified Stock Option (right to buy)
A - Award 500,000 500,000
2012-05-09 2012-05-07 4 APPA AP PHARMA INC /DE/
Rights to Purchase Senior Secured Convertible Notes due 2021
X - Other
2012-05-09 2012-05-07 4 APPA AP PHARMA INC /DE/
Senior Secured Convertible Notes due 2021
X - Other 2,400,000.00
2012-02-03 2012-02-01 4 RDEA Ardea Biosciences, Inc./DE
Common Stock
P - Purchase 426,470 3,733,582 12.90 17.00 7,249,990 63,470,894
2012-01-05 2012-01-03 4 RDEA Ardea Biosciences, Inc./DE
Stock Option (Right to Buy)
A - Award 12,500 12,500
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)